These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 10373224

  • 21. Novel angiotensin receptor subtypes in fowl.
    Nishimura H, Walker OE, Patton CM, Madison AB, Chiu AT, Keiser J.
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1174-81. PubMed ID: 7977843
    [Abstract] [Full Text] [Related]

  • 22. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH.
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [Abstract] [Full Text] [Related]

  • 23. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
    Wang QD, Sjöquist PO.
    Eur J Pharmacol; 1999 Sep 03; 380(1):13-21. PubMed ID: 10513555
    [Abstract] [Full Text] [Related]

  • 24. Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.
    Jin D, Song K, Oka Y, Takai S, Shiota N, Miyazaki M.
    Jpn J Pharmacol; 1997 Nov 03; 75(3):259-66. PubMed ID: 9434257
    [Abstract] [Full Text] [Related]

  • 25. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE, Cohen RB, Skwish S, Delaney CL, Serafino RP, Poss MA, Gu Z, Ryono DE, Moreland S, Powell JR.
    Br J Pharmacol; 1994 Sep 03; 113(1):179-89. PubMed ID: 7812609
    [Abstract] [Full Text] [Related]

  • 26. Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery.
    Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA.
    J Cardiovasc Pharmacol; 2002 Jul 03; 40(1):50-7. PubMed ID: 12072577
    [Abstract] [Full Text] [Related]

  • 27. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
    Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA.
    J Renin Angiotensin Aldosterone Syst; 2002 Sep 03; 3(3):181-7. PubMed ID: 12563569
    [Abstract] [Full Text] [Related]

  • 28. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.
    Chen L, McNeill JR, Wilson TW, Gopalakrishnan V.
    Hypertension; 1995 Jul 03; 26(1):83-8. PubMed ID: 7607737
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sympatholytic properties of several AT1-receptor antagonists in the isolated rabbit thoracic aorta.
    Nap A, Balt JC, Pfaffendorf M, Van Zwieten PA.
    J Hypertens; 2002 Sep 03; 20(9):1821-8. PubMed ID: 12195125
    [Abstract] [Full Text] [Related]

  • 31. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Kawano H, Cody RJ, Graf K, Goetze S, Kawano Y, Schnee J, Law RE, Hsueh WA.
    Hypertension; 2000 Jan 03; 35(1 Pt 2):273-9. PubMed ID: 10642310
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Functional comparison of the antagonistic properties of some Angiotensin II type 1 receptor blockers on the contraction elicited by Angiotensin II and thromboxane A2 on human saphenous veins.
    Hakim A, Stanke-Labesque F, Hoffmann P, Sessa C, Caron F, Cracowski JL, Bessard G.
    J Cardiovasc Pharmacol; 2003 Jul 03; 42(1):42-7. PubMed ID: 12827025
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
    Montón M, Jiménez A, Núñez A, López-Blaya A, Farré J, Gómez J, Zalba LR, Sánchez de Miguel L, Casado S, López-Farré A.
    J Cardiovasc Pharmacol; 2000 Jun 03; 35(6):906-13. PubMed ID: 10836725
    [Abstract] [Full Text] [Related]

  • 37. Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action.
    Christophe B, Libon R, Cazaubon C, Nisato D, Manning A, Chatelain P.
    Eur J Pharmacol; 1995 Aug 04; 281(2):161-71. PubMed ID: 7589203
    [Abstract] [Full Text] [Related]

  • 38. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog.
    Lee BH, Lee SH, Jung YS, Seo HW, Yoo SE, Shin HS.
    J Pharm Pharmacol; 1999 Oct 04; 51(10):1191-200. PubMed ID: 10579691
    [Abstract] [Full Text] [Related]

  • 39. Sympatho-inhibitory properties of various AT1 receptor antagonists.
    Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA.
    J Hypertens Suppl; 2002 Jun 04; 20(5):S3-11. PubMed ID: 12184061
    [Abstract] [Full Text] [Related]

  • 40. Effects of losartan on contractile responses of conductance and resistance arteries from rats.
    Corriu C, Bernard S, Schott C, Stoclet JC.
    J Cardiovasc Pharmacol; 1995 Nov 04; 26(5):688-92. PubMed ID: 8637181
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.